Charming Medical Limited Class A Ordinary Shares (MCTA) Stock Score, Valuation & Financial Research
Charming Medical Limited Class A Ordinary Shares is in the Healthcare sector and Medical - Care Facilities industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 38/100.
Quick answer for MCTA
Charming Medical Limited Class A Ordinary Shares currently has a Wall Street Score of 38/100. The stored market price is $29.36. Its financial score is 53/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Charming Medical Limited Class A Ordinary Shares does
Operating through its subsidiaries and under the Beauty Lab brand in Hong Kong, Charming Medical Limited delivers a comprehensive suite of beauty, wellness, and postpartum services. These services encompass womb-warming therapy, BTS (Beauty, Tailor-made, Slim) pelvic detox, agarwood moxibustion, TCM-inspired prenatal massages, and Indonesian traditional abdominal binding. In addition to these treatments, the company manufactures and distributes various products. Their product line features TCM-inspired supplements, including the Beauty Lab home herbal uterine care patch, probiotic intimate wash, and Yin nourishing pill sets. They also offer beauty products like a ginseng soothing anti-allergy moisturizing wash for various skin issues and solutions for scalp health. The company further provides consultancy services, offering technical training in TCM-inspired therapies and dietary guidanc
MCTA financial snapshot
- Wall Street Score:
- 38/100
- Current price:
- $29.36
- Market capitalization:
- $445.6M
- Revenue:
- $6.2M
- Net income:
- $1.2M
- Free cash flow:
- $138K
- Cash:
- $817K
- Total debt:
- $1.2M
- EPS:
- 0.07
- P/E ratio:
- 414.6x
- Financial score:
- 53/100
- Valuation score:
- 0/100
- Revenue score:
- 32/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $138K, showing positive cash generation.
- The balance sheet shows $817K of cash versus $1.2M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 53/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research MCTA
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.